Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
盐酸美可比林片在健康志愿者中的单次给药耐受性及药动学研究
[Translation] Study on single-dose tolerance and pharmacokinetics of mecobilin hydrochloride tablets in healthy volunteers
在健康志愿者中研究单次口服给予盐酸美可比林片后受试者的耐受性及药动学特征,为Ⅰb期临床制定给药方案提供依据
[Translation] To study the tolerability and pharmacokinetic characteristics of mecobilin hydrochloride tablets after a single oral administration in healthy volunteers, and provide a basis for the formulation of dosing regimen for Phase Ib clinical trials
100 Clinical Results associated with Jiangsu Ouwei Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Jiangsu Ouwei Pharmaceutical Co., Ltd.
100 Deals associated with Jiangsu Ouwei Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Jiangsu Ouwei Pharmaceutical Co., Ltd.